Volume 86, Issue 5, Pages (November 2014)

Slides:



Advertisements
Similar presentations
Volume 74, Issue 3, Pages (August 2008)
Advertisements

Volume 39, Issue 5, Pages (November 2013)
Volume 86, Issue 4, Pages (October 2014)
Volume 80, Issue 4, Pages (August 2011)
Volume 77, Issue 6, Pages (March 2010)
Volume 81, Issue 11, Pages (June 2012)
Volume 88, Issue 5, Pages (November 2015)
Volume 78, Issue 3, Pages (August 2010)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Hui Ying Li, Yoon Sin Oh, Ji-Woong Choi, Ji Yong Jung, Hee-Sook Jun 
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 76, Issue 1, Pages (July 2009)
Volume 56, Issue 4, Pages (October 1999)
Volume 78, Issue 4, Pages (August 2010)
Volume 85, Issue 5, Pages (May 2014)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 84, Issue 2, Pages (August 2013)
Critical role for osteopontin in diabetic nephropathy
Volume 68, Issue 6, Pages (December 2005)
Volume 69, Issue 12, Pages (June 2006)
Volume 78, Issue 9, Pages (November 2010)
Volume 83, Issue 5, Pages (May 2013)
Volume 80, Issue 11, Pages (December 2011)
Volume 88, Issue 3, Pages (September 2015)
Volume 74, Issue 3, Pages (August 2008)
Volume 84, Issue 5, Pages (November 2013)
Volume 80, Issue 9, Pages (November 2011)
Volume 39, Issue 5, Pages (November 2013)
Volume 78, Issue 1, Pages (July 2010)
Volume 87, Issue 1, Pages (January 2015)
Mechanisms of the proteinuria induced by Rho GTPases
Volume 79, Issue 12, Pages (June 2011)
Volume 75, Issue 4, Pages (February 2009)
Volume 87, Issue 1, Pages (January 2015)
Volume 64, Issue 5, Pages (November 2003)
Volume 86, Issue 6, Pages (December 2014)
Expression of HIV transgene aggravates kidney injury in diabetic mice
Volume 77, Issue 11, Pages (June 2010)
Volume 69, Issue 1, Pages (January 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 87, Issue 2, Pages (February 2015)
Volume 93, Issue 1, (January 2018)
Volume 81, Issue 5, Pages (March 2012)
Volume 73, Issue 4, Pages (February 2008)
Volume 76, Issue 4, Pages (August 2009)
Volume 29, Issue 3, Pages (May 2014)
Oliver Vonend, Clare M. Turner  Kidney International 
Liming Wang, Jae-Hyung Chang, Anne F. Buckley, Robert F. Spurney 
Volume 75, Issue 10, Pages (May 2009)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 79, Issue 4, Pages (February 2011)
Volume 127, Issue 3, Pages (September 2004)
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Volume 53, Issue 4, Pages (April 1998)
Volume 77, Issue 4, Pages (February 2010)
Volume 85, Issue 2, Pages (January 2014)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy  Carolina Lavoz, Yenniffer Sánchez Matus,
Volume 82, Issue 2, Pages (July 2012)
Volume 66, Issue 5, Pages (November 2004)
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Volume 82, Issue 3, Pages (August 2012)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Volume 85, Issue 1, Pages (January 2014)
Volume 21, Issue 2, Pages (February 2013)
Volume 72, Issue 2, Pages (July 2007)
Volume 68, Issue 1, Pages (July 2005)
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 86, Issue 5, Pages 979-990 (November 2014) Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice  Federica Barutta, Serena Grimaldi, Irene Franco, Stefania Bellini, Roberto Gambino, Silvia Pinach, Alessandro Corbelli, Graziella Bruno, Maria Pia Rastaldi, Teresa Aveta, Emilio Hirsch, Vincenzo Di Marzo, Gabriella Gruden  Kidney International  Volume 86, Issue 5, Pages 979-990 (November 2014) DOI: 10.1038/ki.2014.165 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Effect of the CB2 deficiency on diabetes-induced nephrin and podocin downregulation. Both nephrin and podocin expressions were assessed in ND-WT (n=12), ND-KO (n=6), DM-WT (n=9), and DM-KO (n=7) mice by immunofluorescence and immunoblotting. Representative immunofluorescence images of (a) nephrin and (b) podocin are shown (× 400), and (c, d) quantification of glomerular staining is reported in the graphs (*P<0.001 DM-WT vs. ND-WT, ND-KO, and DM-KO). (e, g) Representative immunoblots of nephrin and podocin protein expression in total protein extracts from the renal cortex are shown. Tubulin was used as internal control. Results of densitometry analyses are reported in panel (f) for nephrin (*P<0.01 DM-WT vs. ND-WT, ND-KO, and DM-KO) and in panel (h) for podocin (*P<0.001 DM-WT vs. ND-WT and ND-KO; #P<0.05 DM-KO vs. DM-WT). DM, diabetic; KO, CB2−/− knockout; ND, nondiabetic; WT, wild type. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Transmission electron microscopy analysis. Representative electron microscopy images showing glomeruli from both nondiabetic (ND) and diabetic (DM), wild-type (WT) and CB2−/− knockout (KO) mice. (a) The extent of foot processes fusion (#) was similar in WT and KO diabetic mice. (b) Glomeruli from DM-KO mice showed a more prominent mesangial expansion (*) than DM-WT mice. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 CB2 absence worsens diabetes-induced glomerular structural abnormalities and enhances expression of fibrosis markers. Renal cortex samples from ND-WT (n=12), ND-KO (n=6), DM-WT (n=9), and DM-KO (n=7) mice were studied 16 weeks after diabetes induction. (a) Representative PAS staining images (× 400) and (b) quantitation of percentage of mesangial areas are shown. (c) Collagen staining and both (d) type I and (e) type IV collagen mRNA expression were studied by picrosirius red staining and real-time PCR, respectively. (f, g) Glomerular fibronectin expression was assessed by immunofluorescence and (h) renal cortex fibronectin gene expression by real-time PCR. (i) Transforming growth factor (TGF)-β1 and (j) connective tissue growth factor (CTGF) mRNA levels were measured by real-time PCR in total renal cortex. (#P<0.05, ‡P<0.01, and *P<0.001 DM-WT vs. ND-WT; †P<0.05, and §P<0.01 DM-KO vs. DM-WT.) DM, diabetic; KO, CB2−/− knockout; ND, nondiabetic; WT, wild type. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Effect of CB2 deletion on markers of inflammation in diabetic (DM) and nondiabetic (ND) mice. ND-WT (n=12), ND-KO (n=6), DM-WT (n=9), and DM-KO (n=6) mice were studied 16 weeks after diabetes onset. Glomerular monocyte accrual was assessed by counting the number of F4/80-positive cells within the glomeruli. (a) Representative images are shown (× 400) and (b) the number of F4/80-positive cells are reported in the graph. (c) GR1+, (d) monocyte chemoattractant protein 1 (MCP-1), and (e) C-C motif chemokine receptor 2 (CCR2) mRNA levels were measured by real-time PCR on total RNA extracts from the renal cortex, and results corrected for the expression of the housekeeping gene HRPT (hypoxantine phosphoribosyltransferase). (f) Representative images of immunohistochemistry staining for CCR2 are shown (× 400) and (g) quantification of glomerular staining are reported in the graphs. (*P<0.05 DM-WT vs. ND; ‡P<0.05 and §P<0.01 DM-KO vs. DM-WT; #P<0.001 DM-WT and DM-KO vs. others; †P<0.01 and °P<0.001 DM-KO and ND-KO vs. others.) KO, CB2−/− knockout; WT, wild type. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Bone marrow (BM) transplantation study. Wild type, CB2−/− knockout (KO), and lethally irradiated recipient mice reconstituted with BM from either CB2−/− (chimera-KO cko) or WT (chimera-WT cwt) mice were studied 14 weeks after diabetes onset (4–6 mice per group). Podocin expression was measured in renal cortex sections by immunofluorescence. (a–g) Representative immunofluorescence images are shown (× 400) and (h) quantification of glomerular staining is reported in the graph (*P<0.01 DM and DM-WT-cko vs. ND groups; #P<0.05 DM-KO and DM-KO-cwt vs. DM and DM-cko). Fibronectin mRNA levels were measured by real-time PCR on total RNA extracts from the renal cortex, and (i) results were corrected for the expression of the housekeeping gene HRPT (hypoxantine phosphoribosyltransferase) (†P<0.05 DM and DM-WT-cko vs. ND groups, §P<0.05 DM-KO vs. DM-WT and DM-WT-cko; °P<0.01 DM-KO-cwt vs. DM-WT and DM-WT-cko). In (j–l) DM-WT-cko and (m–o) DM-KO-cwt mice, double immunofluorescence for (j, m) CB2 and (k, n) the monocyte marker F4/80+ was performed and (l, o) merged images are shown. The insert in panel (m) shows nuclei counterstained with DAPI (4,6-diamidino-2-phenylindole). Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Glomerular CB1 expression/distribution is not altered in CB2−/− knockout mice. CB1 protein expression was assessed in renal sections from ND-WT (n=12), ND-KO (n=6), DM-WT (n=9), and DM-KO (n=7) mice by (a) immunohistochemistry and (b) quantification of glomerular staining reported in the graph (*P<0.01 DM-WT and DM-KO vs. ND). Double immunofluorescence for CB1 (red) and (c) either the podocyte marker WT-1 (green) or (d) the mesangial cells’ marker α-smooth muscle actin (SMA) (green) was performed in all studied groups and overlapped pictures (Merge) shown (c, d). DM, diabetic; KO, CB2−/− knockout; ND, nondiabetic; WT, wild type. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Effect of CB2 deletion on the endocannabinoid system. Concentrations of (a) endocannabinoid (EC) (anandamide (AEA), 2-arachidonoylglycerol (2-AG)) and (b) endocannabinoid-related molecules (palmitoylethanolamide (PEA) and oleoylethanolamide (OEA)) were measured in the renal cortex from ND-WT (n=4), ND-KO (n=3), DM-WT (n=5), and DM-KO (n=4) mice by isotope dilution liquid chromatography–mass spectrometry. Protein expression of (c) diacylglycerol lipase-α (DAGL-α), (d) monoacylglycerol lipase (MAGL), (e) fatty acid amide hydrolase (FAAH), and (f) N-acyl phosphatidylethanolamine-specific phospholipase D (NAPE-PLD) was assessed in total renal cortex protein extracts by immunoblotting. Tubulin was used as an internal control. Representative immunoblots and results of densitometry analyses are shown. *P<0.01 DM-WT and DM-KO vs. ND; #P<0.05 DM-KO vs. others. DM, diabetic; KO, CB2−/− knockout; ND, nondiabetic; WT, wild type. Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 8 Effect of high glucose and mechanical stretch on CB2 receptor expression in cultured podocytes. Serum-deprived differentiated podocytes were exposed to either (a) high glucose concentration (25mmol/l) for 24, 48, and 72h or (b) mechanical stretch for 12h (black columns). Control cells in normal glucose concentration (7mmol/l made iso-osmolar with mannitol) and in a mechanically stable environment were studied in parallel (white columns). Total proteins were extracted and CB2 expression assessed by immunoblotting. Densitometric analyses and representative immunoblots are shown. Results are expressed as fold change over control (n=3, *P<0.05 stretch vs. control). Kidney International 2014 86, 979-990DOI: (10.1038/ki.2014.165) Copyright © 2014 International Society of Nephrology Terms and Conditions